Sort
85,873 grants matching “alzheimers”
Mapping amyloid, tau, and neurodegeneration markers with neuropsychiatric phenotypes and genotypes in Alzheimer's disease continuum using machine learning
$3,188,901Ganesh Chand · Washington University · RF1 · FY2025 · AG
Role of PS1 in neurodegeneration
$3,188,744Oksana Berezovska · Massachusetts General Hospital · RF1 · FY2019 · AG
UC Davis Alzheimer's Disease Research Center
$3,188,498Charles Decarli · University Of California At Davis · P30 · FY2023 · AG
A Systems Approach to Targeting Innate Immunity in AD
$3,188,314Nilufer Ertekin-Taner · Mayo Clinic Jacksonville · U01 · FY2021 · AG
Understanding and Improving Healthcare Decision-Making and Outcomes for People Living with Alzheimer's Disease and Related Dementias
$3,185,633Katherine Baicker · National Bureau Of Economic Research · P01 · FY2024 · AG
SORL1 and its involvement in Alzheimer's disease pathogenesis and pathophysiology
$3,184,272Scott A Small · Columbia University Health Sciences · P01 · FY2025 · AG
Johns Hopkins Alzheimer's Disease Research Center
$3,184,252Marilyn S Albert · Johns Hopkins University · P30 · FY2021 · AG
Escitalopram for Agitation in Alzheimer Disease
$3,183,018Constantine G Lyketsos · Johns Hopkins University · R01 · FY2016 · AG
Johns Hopkins Alzheimer's Disease Research Center
$3,182,387Marilyn S Albert · Johns Hopkins University · P30 · FY2022 · AG
Yale Alzheimer Disease Research Center
$3,182,375Stephen M Strittmatter · Yale University · P30 · FY2023 · AG
Johns Hopkins Alzheimer's Disease Research Center
$3,180,913Marilyn S Albert · Johns Hopkins University · P30 · FY2023 · AG
Seeds and Strains Derived from Tau Monomer
$3,179,511Marc I Diamond · Ut Southwestern Medical Center · RF1 · FY2020 · AG
The role of microbiota in aging and Alzheimer's disease
$3,179,376Howard L Weiner · Brigham And Women'S Hospital · RF1 · FY2020 · AG
Age-related TDP-43 neuropathology: using disease-driving mechanisms to guide classification
$3,179,031Matthew Daniel Cykowski · Methodist Hospital Research Institute · RF1 · FY2020 · NS
UC Davis Alzheimer's Disease Research Center
$3,178,609Charles Decarli · University Of California At Davis · P30 · FY2022 · AG
Adult Changes in Thought (ACT) Research Program Core B: Clinical Core
$3,178,322Eric B Larson · Kaiser Foundation Research Institute · U19 · FY2021 · AG
AMP-Kinase as a target for neuroprotection in AD
$3,175,735Michael K Lee · University Of Minnesota · RF1 · FY2019 · AG
Exercise and Intensive Vascular Risk Reduction in Preventing Dementia
$3,175,333Rong Zhang · Ut Southwestern Medical Center · R01 · FY2019 · AG
Brain - Plasma Proteomics Biomarker Discovery and Validation in the US and UK
$3,174,907Allan I Levey · Emory University · RF1 · FY2017 · AG
UCSD Alzheimer's Disease Research Center P50
$3,174,023Douglas R Galasko · University Of California, San Diego · P50 · FY2014 · AG
MSUT2 modulates pathological tau in AD and model organisms
$3,173,979Brian C. Kraemer · Seattle Inst For Biomedical/Clinical Res · RF1 · FY2017 · AG
Johns Hopkins Alzheimer's Disease Research Center
$3,173,555Marilyn S Albert · Johns Hopkins University · P30 · FY2024 · AG
Circadian dysfunction and Epigenetic alterations in the pathogenesis of Alzheimer's Disease
$3,173,392Paula Alejandra Desplats · University Of California, San Diego · RF1 · FY2019 · AG
Deep Phenotypic Characterization of Prodromal Dementia with Lewy Bodies
$3,171,435James E Galvin · University Of Miami School Of Medicine · R56 · FY2022 · AG
Alzheimer's Disease Research Center
$3,171,322Thomas M Wisniewski · New York University School Of Medicine · P30 · FY2023 · AG